LIEPHAR
The computed 12-month bankruptcy probability of LIEPHAR is 0.5% (low). The 2024 annual accounts show equity of €823k and a net result of €138k. Equity is growing by ~8.1% per year across the filed fiscal years. Its solvency ranks better than 81% of 866 sector peers (fiscal year 2024). The company has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €823k |
| Net result | €138k |
| Staff (FTE) | 3.1 |
| Better than sector | 81% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 50.3% | 17.3% | |
| Net result | €138k | €14k | |
| Equity | €823k | €100k | |
| Gross operating margin | €312k | €213k | |
| Staff costs | €127k | €219k |
| Fiscal year | 2024 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | €185k |
| Net profit | €138k |
| Cash flow | €156k |
| Staff costs | €127k |
| Income taxes | €11k |
| Dividends | - |
| Total assets | €1.64M |
| Equity | €823k |
| Debt | €812k |
| of which ≤ 1y | €243k |
| of which > 1y | €568k |
| Working capital | €547k |
| Employees (FTE) | 3.1 |
| 2024 | |
|---|---|
| Current ratio | 3.25 |
| Quick ratio | 2.30 |
| Working capital ratio | 33.4% |
| Solvency | 50.3% |
| Debt / equity | 0.99 |
| Long-term debt ratio | 0.69 |
| Interest coverage | 9.44 |
| Gross margin | - |
| Net margin | - |
| ROA | 8.4% |
| ROE | 16.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.64M |
| Fixed assets | 21/28 | €845k |
| Tangible fixed assets | 22/27 | €845k |
| Current assets | 29/58 | €790k |
| Stocks & contracts in progress | 3 | €230k |
| Amounts receivable within one year | 40/41 | €383k |
| Cash & bank | 54/58 | €169k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.64M |
| Equity | 10/15 | €823k |
| Contributions / capital | 10/11 | €150k |
| Reserves | 13 | €34k |
| Accumulated profits (losses) | 14 | €639k |
| Amounts payable | 17/49 | €812k |
| Amounts payable after one year | 17 | €568k |
| Amounts payable within one year | 42/48 | €243k |
| Trade debts payable within one year | 44 | €69k |
| Income statement | ||
| Gross operating margin | 9900 | €312k |
| Operating result | 9901 | €166k |
| Financial income | 75 | €3k |
| Financial charges | 65 | €20k |
| Result before taxes | 9903 | €149k |
| Income taxes | 67/77 | €11k |
| Net result for the period | 9904 | €138k |
| Result to be appropriated | 9905 | €138k |
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Public limited company(014) |
| Incorporation | 12-01-2004 |
| Status | Active |
| Postal code | 5640 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92087F0132/00C000 | Wallonia | 479 m² | 1 · 195 m² | 12.5 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
03-07-2025 1 director appointed, 2 reappointed
- MBM Groupe SRL, Dagelijks bestuur
- Geneviève LIENARD, Commissaris
- Michel MEERT, Bestuurder
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Genevi\u00E8ve LIENARD",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0728.704.778",
"name": "LIEPHARM",
"address": "Place Joseph Meunier 11 \u00E0 5640 Mettet",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": "2025-06-19",
"evidence_quote": "Madame Genevi\u00E8ve LIENARD est reconduite dans sa fonction de repr\u00E9sentante permanente dans la sri LIEPHARM",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2031"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_renew",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Michel MEERT",
"address": "rue Basse 41 \u00E0 5332 Assesse",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2025-06-19",
"evidence_quote": "Monsieur Michel MEERT, domicili\u00E9 rue Basse 41 \u00E0 5332 Assesse dans sa fonction d\u0027administrateur.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2031"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0542.637.202",
"name": "MBM Groupe SRL",
"address": "Avenue Tedesco 26 \u00E0 1160 Auderghem",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e mandate la soci\u00E9t\u00E9 MBM Groupe SRL, dont les bureaux sont \u00E9tablis Avenue Tedesco 26 \u00E0 1160 Auderghem, BCE n\u00B00542.637.202 repr\u00E9sent\u00E9e par Mr Thierry Graulich et/ou Mr Christophe Dereume et/ou Mme Isabelle De Roose aux fins de proc\u00E9der aux diff\u00E9rentes formalit\u00E9s li\u00E9es \u00E0 ces d\u00E9cisions aupr\u00E8s",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": null,
"filing_date": "2025-05-30",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-05-30",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0862.571.213",
"name_full": "LIEPHAR",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "De Roose Isabelle",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | LIEPHAR |